
Caroline Wilson
Consultant breast and acute medical oncologist at The Christie NHS Foundation Trust, Manchester, and UK Acute Oncology Society secretary.
2
APPEARANCES
2
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
Sep 25, 2026
Episode 121: In the Clinic - The Acute Oncology Service - Cancer's Front Door Heroes with Dr Caroline Wilson
16:57
17:03
17:17
17:23

Caroline WilsonGUEST
It was your good old fashioned chemotherapies that caused the toxicities that the patients are coming in with.

Caroline WilsonGUEST
Then if we go back to about five years ago, IO at that time in the whole scheme of AO was still only about 10% because we audited it across South Yorkshire and looked at how much was pure IO tox versus everything else that we give.

Caroline WilsonGUEST
So our tyrosine kinase inhibitors, our chemos, and AO was still only about 10%.

Caroline WilsonGUEST
And I don't think that percentage, I haven't looked at the data in the last year or so, but when I look at my acute oncology daily MDT data, It doesn't feel like it's hugely bigger than that.
M
19:18Michael RoweHOST
And how do you see, on that note of people potentially deteriorating in the community and sort of being able to highlight that and do something about it to prevent admissions, how do you see acute oncology services coordinating or synergising with things like enhanced supportive care services, including things like managing people in virtual wards? And then on top of that, how we bring together, because it feels quite fragmented, it feels like, because things have happened so quickly, know there's immunotherapies come through but then there's now you know all of our androgen receptor pathway inhibitors there's parp inhibitors there's androgen adcs all of these new drugs new toxicities coming through so quickly no one can keep up and so we're kind of building bolting on great ideas i'm thinking specifically about a thing like immunotherapy toxicity services that some trusts will have set up as a standalone service separate to the acute oncology Is there an argument to try and bring all of this under one group or should it be remaining as this sort of bolt-on modular status that we currently run?
Jodi
11:06
11:15
S
10:55Sarah LipscombHOST
I think it universally turns people upside down, regardless of the severity of their trauma.

Caroline WilsonGUEST
I remember she had been in the hospital and I don't recall why she'd been hospitalized.

Caroline WilsonGUEST
There wasn't any evidence of her brain bleed at the time that they did the imaging.
